The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...
Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former ...
Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...
US FDA accepts for review GSK’s BLA for depemokimab for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps: London, UK Tuesday, March 4, 2025, 09:0 ...
The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...
Specialty pharmacy expands access to an innovative, steroid-free treatment NEW PROVIDENCE, NJ, UNITED STATES, March 3, 2025 /EINPresswire / -- ...
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...
Hosted on MSN2d
Medical Report: Are asthma inhalers bad for the environment?Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...
Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback